TradeBeam raises $7M for trade management software

TradeBeam Holdings, a San Mateo, Calif.-based provider of software that manages global trade agreements online, has brought in $7 million to extend a $3 million round earmarked for expansion of its operations in China. Its product helps companies make sure they are complying with export… Continue Reading

Actelis scores $4.7M for copper-wire ethernet

Actelis Networks, maker of equipment that lets ethernet run over copper wires, tacked $4.7 million more onto its previously raised $15 million sixth round of funding, reports VentureWire. With fiber optics becoming too pricey for many businesses, copper has become a popular alternative.

The Fremont, Calif.-based… Continue Reading

Neovista sees $18M to treat eye disorders

Neovista, a Fremont, Calif.-based biotech company specializing in eye diseases, says it raised $18 million in a fourth round of funding to commercialize its new device. The money came from Accuitive Medical Ventures, Carlyle Group, Essex Woodlands Health Ventures, MPM Capital, SV Life Sciences and… Continue Reading

Proteus snaps up $30M to take on heart failure

Proteus Biomedical Inc., a company developing microscopic electromechanical devices capable of one day treating or preventing congestive heart failure, brought in more than $30 million in its first call for fourth round financing. It’s original goal was $28.6 million, but CEO Andrew Thompson says the… Continue Reading

Former Time editor Pearlstine leaves Carlyle for Bloomberg — What next?

Former Time editor Pearlstine leaves Carlyle for Bloomberg — What next?

Norman Pearlstine, the former editor in chief of Time Inc., has left the politically connected buyout firm Carlyle after less than two years, and joined the financial media company, Bloomberg.

The departure comes at a time when Carlyle is going through serious turmoil, with prominent partner… Continue Reading

Roundup: AMD falls, Sequoia expands, and more

Roundup: AMD falls, Sequoia expands, and more

Here’s the latest action:

Advanced Micro Devices is in a world of hurt — The Sunnyvale, Calif. chip company lost $358 million on revenues of $1.5 billion in the quarter. It cited a tough outlook for the computer market, but it is clearly hurting from Intel’s… Continue Reading

Health-info site HealthCentral Network pulls in $50M

Health-info site HealthCentral Network pulls in $50M

(UPDATED: IAC put out a release this morning — see below.)

The HealthCentral Network, an Arlington, Va., collection of health-information sites, raised roughly $50 million, paidContent reports. Investors included some big names, include Barry Diller’s online media and commerce conglomerate IAC, Sequoia Capital, Carlyle Group and Polaris… Continue Reading

REVShare, raises $20M for cost-per-action TV ad network

REVShare, a Temecula, Calif.’ company that lets advertisers to bid for television time on a cost-per-action basis, has raised $20 million in a first round of funding.
The private equity firm Carlyle Group and H.I.G. Ventures co-led the round.

The auction/exchange model contrasts with the traditional method… Continue Reading

Life sciences briefing: Thursday, Nov. 29, 2007

Life sciences briefing: Thursday, Nov. 29, 2007

Featured companies: Adenosine Therapeutics, Allylix, Caprotec BioAnalytics, Equipois, F-Star, Insightec, MedNets.com, Renal Solutions, Transport Pharmaceuticals, VeriCare Management

UPDATED: Expanded items on Transport Pharmaceuticals, InSightec and VeriCare Management.

Transport Pharma aims for $35M for cold-sore treatment — Framingham, Mass.-based Transport Pharmaceuticals, a dermatology-focused biotech developing a new treatment for cold… Continue Reading

Carlyle raises $605M fund for late-stage deals, despite poor performance

The venture arm of private-equity firm Carlyle Group has raised a $605 million fund to invest in later-stage deals and buyouts, despite poor performance so far on its prior fund.

Carlyle expects to invest $20 million to $30 million in companies that are mature and producing… Continue Reading

Sweden’s Meda acquires specialty pharma MedPointe for $820M

Meda, a Swedish specialty-pharmaceutical company, agreed to acquire MedPointe, another specialty pharma in Somerset, N.J., for roughly $820 million in cash and stock. Meda’s release — and be careful, as it’s a little difficult to slog through even though it’s (ostensibly) written in English —… Continue Reading

ThermaSource, geothermal co., raises cash

ThermaSource, a Santa Rosa, Calif. provider of drilling, engineering and consulting services to the geothermal energy sector, has raised an undisclosed amount of cash from US Renewables Group, Riverstone Holdings and The Carlyle Group.

From the statement:

Funds will come from USRG and Carlyle/Riverstone Renewable Energy… Continue Reading